* Amendment extends Firmenich's access to new innovations from the Senomyx
Sweet Taste Program

* Amendment allows Senomyx to market certain sweet flavor ingredients directly
to Flavor Companies & provides additional development funding commitments from

* Senomyx & Firmenich initiate Supply Agreement for sweet flavor ingredients

PR Newswire

SAN DIEGO, Calif. and GENEVA, Switzerland, April 11, 2013

SAN DIEGO, Calif. and GENEVA, Switzerland, April 11, 2013 /PRNewswire/
--Senomyx, Inc. (NASDAQ: SNMX), a company using proprietary taste science
technologies to discover, develop, and commercialize novel flavor ingredients,
and Firmenich, the world's largest privately-owned fragrance and flavor
company, announced today that the companies have amended and restated their
Sweet Taste Program collaboration agreement. The amendment extends the period
of research funding from Firmenich for Senomyx's Sweet Taste Program through
July 2016. The associated extension payment and incremental committed
research and development funding will provide Senomyx with significant funding
over the next several years.

The amended agreement provides that Firmenich will have exclusive rights to
commercialize certain Senomyx sweet flavor ingredients discovered under the
collaboration in food and select beverage product categories for a period of
time. After this initial period, Senomyx will begin selling the flavor
ingredients to other flavor companies while Firmenich continues sales to food
and beverage companies. The amendment does not impact Senomyx's other
collaborative agreements regarding the use of its flavor ingredients.

Senomyx's initiation of its new direct sales strategy is intended to
accelerate the Company's transformation into a profitable company by expanding
its focus from discovery & development into commercialization. Senomyx's
flavor ingredient portfolio will initially focus on sweet flavor modifiers,
which can be used to restore the desired taste profile of products in which
sucrose has been reduced. The first product will be S9632, which Senomyx
intends to sell to flavor companies for end-use in non-alcoholic and powdered
beverages, with the anticipated availability of commercial quantities of S9632
by the fourth quarter of 2013. The sweet flavor modifier S6973 will become
available for sale by Senomyx for use in food and certain beverage categories
at a future date. In addition, Senomyx may also decide in the future to
directly commercialize other flavor ingredients to expand its portfolio and
further support the direct sales strategy. 

With this renewed agreement, Firmenich continues its long-standing tradition
of investing in discovery and innovation. Firmenich expects this agreement to
reinforce its leadership position in taste modulation within the Flavor
industry as the company offering the most advanced range of flavor modulators.
Working closely with clients and partners around the world, Firmenich remains
committed to providing flavor solutions that improve the taste of food and
beverageswith enhanced nutritional profiles.

Concurrent with the amendment, Senomyx and Firmenich have also entered into a
Supply Agreement under which Firmenich has agreed to supply Senomyx with
commercial quantities of certain sweet flavor ingredients. The Supply
Agreement has a term of ten years, and is exclusive through 2017. This
relationship streamlines and accelerates the launch of Senomyx's direct sales
strategy, without the Company having to incur the cost of sourcing and
establishing manufacturing capabilities at this time.

"Firmenich's extension of our agreement with Senomyx ensures our continued
leadership in flavor modulation," stated Patrick Firmenich, Chief Executive
Officer of Firmenich. "The combination of our technology with the innovation
from Senomyx creates a unique competitive advantage for our customers."

"The initiation of Senomyx's new direct sales strategy and the associated
amendment of our Sweet Taste Program collaboration agreement with Firmenich
provide short-term financial benefits for Senomyx and significantly increase
the potential mid-to-long term revenue generated from the commercialization of
our flavor ingredients. Firmenich has been a valued partner for Senomyx, and
we look forward to our expanded relationship with them as we commence this
promising new strategy," commented Kent Snyder, Chief Executive Officer of

About Senomyx, Inc. (

Senomyx is using proprietary taste science technologies to discover, develop,
and commercialize novel flavor ingredients. These include modifiers of Sweet
and Salt flavors, as wells as Savory Flavors, Bitter Blockers, and Cooling
Agents. The Company is also engaged in a new effort to discover and develop
natural high-potency sweeteners. Senomyx sells its flavor ingredients
directly to flavor companies. In addition, Senomyx has collaborative
agreements with global food, beverage, and ingredient supply companies, some
of which are currently marketing products that contain Senomyx's flavor
ingredients. Its corporate socially responsible activities are described on
the Senomyx Cares blog at For more
information, please visit

About Firmenich, Inc. (

Firmenich is the world's largest privately-owned company (No.2 worldwide) in
the fragrance and flavor business. Founded in Geneva, Switzerland, in 1895,
Firmenich has created many of the world's best-known perfumes and flavors
enjoyed around the world, every day. Our passion for smell and taste and a
commitment to our clients lies at the heart of our success. Focused, with a
long term vision, Firmenich invests around 10% of its turnover in R&D
annually, reinforcing our expertise in creativity and innovation. Firmenich
had an annual turnover of 2.64 billion Swiss Francs at end June 2012. More
information about Firmenich is available at

Forward-Looking Statements

Statements contained in this press release regarding matters that are not
historical facts are "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Because such statements are
subject to risks and uncertainties, actual results may differ materially from
those expressed or implied by such forward-looking statements. Such statements
include, but are not limited to, statements regarding: Senomyx's ability to
become a profitable company; Senomyx's ability to sell sweet and other flavor
ingredients directly to flavor companies pursuant to the direct sales
strategy; the anticipated timing and scope of commercial launch under the
direct sales strategy of S9632 and S6973 and Senomyx's other flavor
ingredients; Senomyx's potential for increased mid-to-long term revenue; the
anticipated funding under Senomyx's collaboration agreement with Firmenich;
and the expectation that Senomyx's supply agreement with Firmenich will
streamline and accelerate the launch of the direct sales strategy. Risks that
contribute to the uncertain nature of the forward-looking statements include:
Senomyx has no experience in manufacturing, marketing, or selling flavor
ingredients on a commercial scale and may not successfully implement its
direct sales strategy; Senomyx is currently dependent on its product discovery
and development collaborators for all of Senomyx's revenue; Senomyx is
currently dependent on its current and any future product discovery and
development collaborators to develop, manufacture and commercialize any flavor
ingredients Senomyx may discover; Senomyx may not be able to establish new
collaborations or other business arrangements and/or maintain existing
collaborations on acceptable terms; large companies are typically
conservative when implementing changes to their branded products, and may not
begin or expand their use of Senomyx flavor ingredients when expected or at
all; Senomyx or its collaborators may be unable to obtain and maintain the
regulatory approvals required for novel flavor ingredients to be incorporated
into products that are sold; even if Senomyx or its collaborators receive a
regulatory approval and incorporate Senomyx flavor ingredients into products,
those products may never be commercially successful; Senomyx flavor
ingredients may not be useful or cost-effective for formulation into products;
Senomyx or its collaborators may be unable to manufacture Senomyx flavor
ingredients at commercial scale; Senomyx's ability to compete in the flavor
ingredients market may decline if Senomyx does not adequately protect its
proprietary technologies; and Senomyx's discovery and development programs may
not be successful or result in the discovery of new flavor ingredients that
are commercially viable. These and other risks and uncertainties are described
more fully in Senomyx's most recently filed SEC documents, including its
Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, under the
headings "Risks Related to Our Business" and "Risks Related to Our Industry."
All forward-looking statements contained in this press release speak only as
of the date on which they were made. Senomyx undertakes no obligation to
update such statements to reflect events that occur or circumstances that
exist after the date on which they were made.

Senomyx Contact:                                                  Firmenich Contact:

Gwen                                                               Kristina Babbitt
Senomyx, Inc.                                                      Firmenich

Vice President, Investor Relations      Manager of Global
                                                                   Communications, Flavors
& Corporate Communications      (609) 580-4745

SOURCE Senomyx

Press spacebar to pause and continue. Press esc to stop.